Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER)-Reference-Cited by-同舟云学术

Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER)

Published:2013-02-13 Issue:3 Volume:27 Page:368-378
ISSN:0902-0063
Container-title:Clinical Transplantation
language:en
Short-container-title:Clin Transplant

Author:

Schlitt Hans J.¹,Jonas Sven²,Ganten Tom M.³,Grannas Gerrit⁴,Moench Christian⁵,Rauchfuss Falk⁶,Obed Aiman⁷,Tisone Giuseppe⁸,Pinna Antonio D.⁹,Gerunda Giorgio E.¹⁰,Beckebaum Susanne¹¹

Affiliation:

1. Department of Surgery; University of Regensburg; Regensburg; Germany

2. Department of Abdominal and Transplantation Surgery; University Medical Center Leipzig; Leipzig; Germany

3. Department of Gastroenterology, Internal Medicine; University of Heidelberg; Heidelberg; Germany

4. Department of General, Visceral and Transplantation Surgery; Hannover Medical School; Hannover; Germany

5. Hospital for General and Visceral Surgery; Clinical Center of the Johann Wolfgang Goethe University; Frankfurt; Germany

6. Department of General, Visceral and Vascular Surgery; University Hospital Jena; Jena; Germany

7. Transplant Surgery; Department of Surgery; University Medical Center Göttingen; Göttingen; Germany

8. Surgery and Transplantation; University Hospital Policlinico di Tor Vergata; Rome; Italy

9. Department of General Surgery and Transplantation; S. Orsola Hospital; University of Bologna; Bologna; Italy

10. Liver and Multivisceral Transplantation Unit; University of Modena and Reggio Emilia; Modena; Italy

11. Department of General, Visceral and Transplantation Surgery; University Hospital Essen; Essen; Germany

Publisher

Wiley

Subject

Transplantation

Reference27 articles.

1. Long-term survival after liver transplantation in 4,000 consecutive patients at a single center;Jain;Ann Surg,2000

2. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation;The U.S. Multicenter FK506 Liver Study Group;N Engl J Med,1994

3. Nephrotoxicity of cyclosporine in liver transplantation;Iwatsuki;Transplant Proc,1985

4. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506;Platz;Transplantation,1994

5. Nephrotoxicity of immunosuppressive drugs: long-term consequences and challenges for the future;De Mattos;Am J Kidney Dis,2000

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cost-utility analysis of prolonged-release tacrolimus relative to immediate-release tacrolimus and ciclosporin in liver transplant recipients in the UK;Journal of Medical Economics;2016-06-01

2. Protecting the Kidney in Liver Transplant Recipients: Practice ‐ Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice;American Journal of Transplantation;2016-04-22

3. Abdominalchirurgie trifft Nephrologie: Wichtige nephrologische Aspekte vor und nach Nieren- bzw. Lebertransplantation;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2015-11-12

4. Overview of the Indications and Contraindications for Liver Transplantation;Cold Spring Harbor Perspectives in Medicine;2014-05-01

5. Liver transplantation for malignancy: Current treatment strategies and future perspectives;World Journal of Gastroenterology;2014